News

Initial results of an investigator-initiated phase 4 trial suggest that blocking interleukin-12 (IL-12) and IL-23 may reduce cardiovascular inflammation associated with psoriasis, researchers reported at AAD 2018.

Diagnosing PRP is challenging because it can mimic eczema, psoriasis, or even ichthyosis. Biologic treatment for refractory cases considered, researchers said at AAD 2018.

While the vast majority of basal cell carcinomas are treated and resolved with surgery, systemic therapy with one of the two hedgehog pathway inhibitors could be a treatment option for unresectable or metastasized disease, researchers reported at the American Academy of Dermatology annual meeting in San Diego this week.

Injectable aesthetic products recently FDA-approved or in late stages of development include polycaprolactone, a new hyaluronic acid and multiple neuromodulators.

The transgender dermatology patient may face a unique set of challenges doctors should be prepared to address, says Dr. Brian Ginsberg.

With one approved biologic available and many more under investigation, the future of treatment for hidradenitis suppurativa looks very promising.

Speaking at the American Academy of Dermatology annual meeting in February, Dr. Brett Coldiron described challenges dermatologists should be prepared for this year, including Medicare payment reductions, insurers' cost-saving strategies and practice consolidations.

This week during the annual meeting of the American Academy of Dermatology in San Diego, Robert Sidbury, M.D., addressed developments in atopic dermatitis treatments since the publication of treatment guidelines in 2014.

During the American Academy of Dermatology’s annual meeting, physicians addressed the monumental changes that have occurred since the advent of biologic therapy for systemic autoimmune conditions, such as psoriasis and atopic dermatitis. Today, some patients are able to achieve complete disease clearance. Although there may be viable treatments for these conditions, access to care and medication adherence remain top issues, physicians say.

Multidisciplinary skin cancer care is an approach that might not only improve patient outcomes, but also professional satisfaction, researchers reported at AAD 2018 this week in San Diego.

There's been much debate in the literature about the need for and role of vitamin D, which may encourage patients to overdo vitamin dosing, researchers said at AAD 2018 this week.

Female patients with hormonal acne that typically flares before or after menstrual cycles may be ideal candidates for spironolactone, said Emmy M. Graber, M.D., president of the Dermatology Institute of Boston who spoke at AAD 2018 in San Diego this week.

.

Dermatology Times will be reporting from the AAD annual meeting this week in San Diego. Visit our conference news page to follow the developments from the meeting.

.

Fear associated with perceived pain from injectable biologics has been shown to be successfully addressed by employing anchoring bias interventions, researchers report in JAMA Dermatology.

The microbiome is one of the most popular areas of skin research at present. Many dermatologic diseases are accompanied by abnormal microbiomes beginning with atopic dermatitis, says Dr. Zoe Diana Draelos in her monthly column, Cosmetic Conundrums.

Dermatologists recommend moisturizers for patients who suffer from atopic dermatitis, contact dermatitis and psoriasis. Some over-the-counter moisturizers contain allergens patients should avoid. For details, print our table-of-the-month.

In this issue of Dermatology Times, we feature pediatric dermatology research, beginning with advances in junctional epidermolysis bullosa that led to the development of new skin for one young patient.

Balancing a career or business, a family and a household is a given for many of us. When it comes to keeping cool and maintaining relationships with family, colleagues and our patients, communication and education are key. Here's how one tool can help.

Looking for how to build strong business relationships? Here's a checklist to help you connect more effectively with current and potential partners.

Pediatricians respond to the first successful gene therapy treatment for epidermolysis bullosa.

A daily capsule of a cocktail of probiotics may reduce both the severity symptoms in moderate atopic dermatitis and the need for topical corticosteroids to treat symptom flare ups in children.

Avoiding and treating vascular compromise with hyaluronic acid (HA) injections requires understanding the subtleties of underlying facial anatomy and keeping a well-stocked arsenal of treatments for impending necrosis.

PeDRA and NSP authors new consensus statement for pediatric psoriasis. Interdisciplinary care (dermatologist and pediatricians) is critical. Regular screening for common comorbidities is recommended.

Specific training criteria and phone management policy and procedures to help your dermatology practice blow the competition away.

Litigation is largely due to a practitioner’s lack of training and the lack of informed consent for the patient.

All children, but healthy controls, had a higher likelihood of behavioral issues. ADHD symptoms of attention, hyperactivity and impulse control, were higher in AD children. Quality of life lower in affected children.

A survey of pediatric dermatologists and rheumatologists reveals wide variation in how patients with pediatric morphea are treated.

The American Academy of Dermatology annual meeting - Feb. 16-20 in San Diego - will highlight the status of new systemic treatments for chronic skin conditions, such as moderate-to-severe atopic dermatitis and psoriasis; in addition to new treatments for inflammatory skin conditions. Bookmark this site to follow the developments.